RhoG-Binding Domain of Elmo1 Ameliorates Excessive Process Elongation Induced by Autism Spectrum Disorder-Associated Sema5A

Bibliographic Details
Title: RhoG-Binding Domain of Elmo1 Ameliorates Excessive Process Elongation Induced by Autism Spectrum Disorder-Associated Sema5A
Authors: Miyu Okabe, Yuki Miyamoto, Yuta Ikoma, Mikito Takahashi, Remina Shirai, Mutsuko Kukimoto-Niino, Mikako Shirouzu, Junji Yamauchi
Source: Pathophysiology, Vol 30, Iss 4, Pp 548-566 (2023)
Publisher Information: MDPI AG, 2023.
Publication Year: 2023
Collection: LCC:Physiology
Subject Terms: Sema5A, differentiation, autism spectrum disorder, RhoG, N1E-115, Physiology, QP1-981
More Details: Autism spectrum disorder (ASD) is a neurodevelopmental disorder that includes autism, Asperger’s syndrome, and pervasive developmental disorder. ASD is characterized by poor interpersonal relationships and strong attachment. The correlations between activated or inactivated gene products, which occur as a result of genetic mutations affecting neurons in ASD patients, and ASD symptoms are now of critical concern. Here, for the first time, we describe the process in which that the respective ASD-associated mutations (Arg676-to-Cys [R676C] and Ser951-to-Cys [S951C]) of semaphorin-5A (Sema5A) localize Sema5A proteins themselves around the plasma membrane in the N1E-115 cell line, a model line that can achieve neuronal morphological differentiation. The expression of each mutated construct resulted in the promotion of excessive elongation of neurite-like processes with increased differentiation protein markers; R676C was more effective than S951C. The differentiated phenotypes were very partially neutralized by an antibody, against Plexin-B3 as the specific Sema5A receptor, suggesting that the effects of Sema5A act in an autocrine manner. R676C greatly increased the activation of c-Jun N-terminal kinase (JNK), one of the signaling molecules underlying process elongation. In contrast, the blocking of JNK signaling, by a chemical JNK inhibitor or an inhibitory construct of the interaction of RhoG with Elmo1 as JNK upstream signaling molecules, recovered the excessive process elongation. These results suggest that ASD-associated mutations of Sema5A, acting through the JNK signaling cascade, lead to excessive differentiated phenotypes, and the inhibition of JNK signaling recovers them, revealing possible therapeutic targets for recovering the potential molecular and cellular phenotypes underlying certain ASD symptoms.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1873-149X
Relation: https://www.mdpi.com/1873-149X/30/4/40; https://doaj.org/toc/1873-149X
DOI: 10.3390/pathophysiology30040040
Access URL: https://doaj.org/article/a0fa643f56824a1d8a5456b4ebafe19b
Accession Number: edsdoj.0fa643f56824a1d8a5456b4ebafe19b
Database: Directory of Open Access Journals
More Details
ISSN:1873149X
DOI:10.3390/pathophysiology30040040
Published in:Pathophysiology
Language:English